DOES YOUR CHILD WHEEZE? JOIN OUR STUDY LOOKING AT A TREATMENT FOR ASTHMA AND BREATHING PROBLEMS!

DOES YOUR CHILD WHEEZE?  JOIN OUR STUDY LOOKING AT A TREATMENT FOR ASTHMA AND BREATHING PROBLEMS!

Overview

Does your child experience breathing difficulties due to asthma, wheezing or allergies?

Researchers at Indiana University School of Medicine and Riley Children's Hospital are investigating a treatment for asthma in young children to determine if it:

  1. Helps prevent asthma as children grow older;
  2. Lessens the severity of breathing problems;
  3. Stops young kids from developing new allergies or reduce existing allergies;
  4. Decreases wheezing during and after the treatment period.
 

Description

Who Is Eligible
  • Children 2-3 years of age
  • Family history of asthma, allergies or eczema
  • Had wheezing symptoms in the past year
What Is Involved
Children taking part in this study will be placed by random, like a flip of a coin, into one of two groups: a group that will receive the study drug Omalizumab (also known as Xolair) or a group that will receive a placebo.


Participants will receive this medicine by injection every 4 weeks for 2 years and will then be followed for an additional 2 years:

 
Years 1 and 2
  • Receive an injection of either the study drug, Omalizumab, or placebo every 4 weeks.
Years 3 and 4
  • Attend study visits every 4 months for clinical assessment, management of respiratory symptoms, and completion of study questionnaires
  • Participate in monthly phone calls to assess how your child is doing.
  • No injections will take place during years 3 and 4
Study visits will take place at Riley Children’s Clinical Research Center in Indianapolis.
 
Participants will be compensated for their time and could receive up to $2,560 for completed study visits and telephone calls.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions: asthma,eczema,allergy,allergies
  • Age: Between 2 Years - 3 Years
  • Gender: Male or Female

Eligibility Criteria:
  • Children 2-3 years of age
  • Family history of asthma, allergies or eczema
  • Had wheezing symptoms in the past year

Additional Information:
For more information about the PARK (Preventing Asthma in HIgh Risk Kids) Study, please visit the study website at: www.Parkstudy.org

Updated on 30 Nov 2022 . Study ID: TX11354

Pre-Screener

Check if you are eligible Enter contact details Select a site

How old is your child?

None

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center